Vascular Biogenics Ltd.
(NASDAQ : VBLT)

( )
VBLT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.55%78.161.0%$1909.23m
AMGNAmgen, Inc. 1.17%214.051.3%$940.05m
REGNRegeneron Pharmaceuticals, Inc. -0.05%504.002.6%$851.64m
BIIBBiogen, Inc. 2.04%317.741.5%$812.34m
VRTXVertex Pharmaceuticals, Inc. 3.21%263.501.9%$673.50m
MRNAModerna, Inc. -1.56%34.100.0%$562.49m
ILMNIllumina, Inc. 3.96%289.013.5%$512.65m
ALXNAlexion Pharmaceuticals, Inc. 2.06%97.892.0%$309.28m
AAgilent Technologies, Inc. 1.65%75.501.6%$233.64m
INCYIncyte Corp. 0.00%85.112.5%$212.70m
EXASEXACT Sciences Corp. 2.78%64.0021.0%$184.73m
SGENSeattle Genetics, Inc. 2.43%127.496.1%$174.49m
BMRNBioMarin Pharmaceutical, Inc. 0.00%82.774.3%$160.44m
NVAXNovavax, Inc. -1.99%15.78114.7%$122.91m
IMMUImmunomedics, Inc. 3.62%19.4611.9%$118.92m

Company Profile

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.